|
Featured Advisors
|
Tuesday December 04, 2012
by David Fried, editor The Buyback LetterWe bought biotech giant Amgen ( AMGN) a couple of times back in 2009, and again a few months ago in May. We are once again adding the stock to our buyback model portfolio.
A biotechnology pioneer since 1980, Amgen was one of the first companies to realize biotech’s promise in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses around the world. Amgen has a deep and broad pipeline of potential new medicines, and has strong partners -- such as Wyeth, Pfizer and Johnson & Johnson -- for some of its products. The company’s new experimental cholesterol fighting drug shows promise in a new study, and good results recently lifted the share price. Amgen has a market cap of $66.63 billion, a P/E ratio of 17.2, and shares are up about 34% year to date. Analysts praise it for revenue growth, notable return on equity, reasonable valuation levels, solid stock price performance and compelling growth in net income. In the last 12 months, management has reduced shares outstanding by 12.1%. Learn more about this financial newsletter at David Fried's The Buyback Letter.Related articles:
|
News Flash
|
Wednesday May 22, 2013
US Natural Gas ETF: On a roll |
by Doug Fabian, editor Successful Investing
One area I think is ready for a new buy is natural gas. After experiencing a sharp decline from November through early January, natural gas prices have been on a roll.
|
Read more...
|
|
Tuesday May 21, 2013
Split buys? HOMB and Noble Energy |
by Neil Macneale, editor 2-for-1 Stock Split Newsletter
Each month, we add one stock to our model portfolio based upon those companies that have announced 2-for-1 stock splits; after a meager number of splits over the past year, we have a nice collection of six splits elect from this month.
|
Read more...
|
|
Tuesday May 21, 2013
WisdomTree targets global bonds |
by Mark Salzinger, editor The Investor's ETF Report
While most investors diversify the equity portions of their portfolio with allocations to foreign stocks, few diversify their bond holdings internationally. WisdomTree recently introduced the first ETF to invest in a truly global portfolio of corporate bonds.
|
Read more...
|
|
Monday May 20, 2013
Express Scripts: Obamacare buy |
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor
I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.
|
Read more...
|
|
Monday May 20, 2013
Hodges: High conviction funds |
by Walter Frank, editor MoneyLetter
Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.
|
Read more...
|
|
Friday May 17, 2013
United Natural: A play on Whole Foods |
by Mark Skousen, editor Hedge Fund Trader Alert
We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).
|
Read more...
|
|
Thursday May 16, 2013
Timing expert eyes India |
by Sy Harding, editor Street Smart Report
The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.
|
Read more...
|
|
Wednesday May 15, 2013
Value investor goes with Guess |
by Charles Mizrahi, editor Hidden Values Alert
Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.
|
Read more...
|
|
Wednesday May 15, 2013
MGAM: Bingo, lotteries, casinos |
by Jim Oberweis, Jr., editor The Oberweis Report
Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.
|
Read more...
|
|
Tuesday May 14, 2013
Fidelity expert: Bowers' bond bets |
by Jack Bowers, editor Fidelity Monitor & Insight
If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.
|
Read more...
|
|
|
